Charalampos Filippatos

15PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersAutoimmunityPharmacogenomicsMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 21, 2026
A prospective study of familial predisposition to plasma cell dyscrasias.

|Jul 21, 2026
Management and long-term haematological and neurological outcomes of Immunoglobulin M and Waldenström's macroglobulinaemia-related neuropathy: A single-centre experience.

|Jun 26, 2026
Efficacy and Safety of PD-1 Inhibitor-Based Regimens in Patients with Melanoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

|May 27, 2026
Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort.

|Apr 16, 2026
Real-World Outcomes of Mycosis Fungoides and Site-Specific Nodal Involvement: A Registry-Based Study of 25 467 Patients.

|Mar 28, 2026
Real-World Experience with Approved CAR T-Cell Therapies Ciltacabtagene Autoleucel and Idecabtagene Vicleucel in 1272 Relapsed/Refractory Multiple Myeloma Patients.

Charalampos Filippatos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis

Pageof 3

Frequent Collaborators

13 joint publications

Ioannis Ntanasis-Stathopoulos

9 joint publications

Evangelos Terpos

7 joint publications

Efstathios Kastritis

5 joint publications

Despina Fotiou